| 000 | 00873 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250513132604.0 | ||
| 264 | 0 | _c19980205 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a0098-6577 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMauer, M | |
| 245 | 0 | 0 |
_aDiabetic nephropathy as a model for the use of renal structural endpoints in clinical trials. _h[electronic resource] |
| 260 |
_bKidney international. Supplement _cDec 1997 |
||
| 300 |
_aS155-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xpathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xpathology |
| 700 | 1 | _aFioretto, P | |
| 773 | 0 |
_tKidney international. Supplement _gvol. 63 _gp. S155-8 |
|
| 999 |
_c9377034 _d9377034 |
||